Early COVID Vaccine Results Bode Well for an Approval This Year
The data are preliminary, however, and it is not yet clear whether the vaccine protects against severe disease
COVID-19
Don’t Expect a COVID Vaccine before the Election
A vaccine made by Pfizer could seek emergency approval by the third week of November, but it likely won’t be available to the public until mid- to late 2021
‘Warp Speed’ COVID-19 Vaccine Efforts Aim for Diverse Volunteers and Long-Lasting Protection
The Trump administration’s Operation Warp Speed program is backing six efforts with the ambitious goal of delivering an effective vaccine by January
For Experts Who Study Coronaviruses, a Grim Vindication
They warned that the next great pandemic would be a coronavirus, but research funding went to studying other threats.
Watcher in the wastewater
Research groups around the globe are looking to see whether urban wastewater monitoring can be integrated into surveillance systems for SARS-CoV-2 and other pathogens.
Genetic Engineering Could Make a COVID-19 Vaccine in Months Rather Than Years
Candidates are speeding toward human trials